World Vaccine Congress 2022
Unmatched experience bringing vaccines to market
With unprecedented innovation and number of vaccines in development globally, significant investments are being made to prevent disease, which is leading to an increasingly competitive race to market.
New challenges related to equitable distribution, engagement with consumers, HCPs, IDNs, payers, policy and even regulatory dynamics, make choosing the right partner for bringing your vaccine to market globally more important than ever.
Experts throughout the product development lifecycle
Our unique approach brings experts under one roof across clinical and commercial to create a Global Vaccine Center of Excellence that can help navigate your challenges and solve them more quickly, increasing the likelihood of regulatory approval and maximizing commercial success.
Roundtable: What Have We Really Learned From
COVID-19 — And Will We Be Better Prepared for the Next Pandemic?
Tuesday, April 19th | 11:40am ET
Accelerating Drug and Vaccine Development During Infectious Disease Outbreaks
Wednesday, April 20th | 12:10pm ET
Lynlee Burton, MBA
Vice President, Clinical Development, Vaccines, Syneos Health
Darin Seehafer
Executive Director, Infectious Diseases and Vaccines, Syneos Health
Want to learn more? Explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:
Fact Sheet: Vaccines Center of Excellence
Article: Quest for Outbreak Preparedness
Case Study: Maternal RSV Immunization
The Syneos Health Podcast, Coronavirus Special Edition: The Clinical Experience
